Patent protection for pharmaceuticals in turkey

Some of the most notable changes brought by IP Law in the new Patent system are as following: The notable improvement is that a post-grant opposition system is brought by the new IP law in line with the system ruled in Article 99 EPC. This practice has now been changed and the third parties will have a right to file an opposition instead of costly litigation within six months as of the date of publication of the grant in official bulletin. Abolition of seven-year patent system:

Patent protection for pharmaceuticals in turkey

Protocol agreement with the Republic of Belarus for co-operation and production of pharmaceuticals A protocol agreement was signed between Incepta Pharmaceuticals Ltd and the Department of the Public Health of the Republic of Belarus for co-operation and production of pharmaceuticals.

Humayun Kabir, National Professor M. Syed Abu Jafar Md. Musa were present in the inauguration program as special guests. At present our Government needs to spend several hundred crore Taka to import the necessary vaccines for EPI program. But, now we can save huge amount of foreign currency for such initiative of Incepta Vaccine Ltd.

He appreciated much to see such a world class vaccine plant and its facilities. Their initiative makes a remarkable appreciation to reduce the dependency on foreign medicine. But now we are manufacturing vaccines in our own country. Muktadir promised to make all these high-tech and life saving vaccines available and affordable for the people of our country and sought overall assistance from the Government of Bangladesh for such endeavor.

Incepta Vaccine Ltd is the first Human vaccine company in Bangladesh, developed with primary objective to provide preventive medicine to vast majority of population at an affordable price. It is a new state of the art facility to manufacture vaccine in Bangladesh for the first time. It has the following unique features: Each area has dedicated HVAC system to prevent cross contamination.

Each filling line has a sterilizing autoclave and decontamination autoclave. It has well designed spacious cold rooms to store raw materials and finished products. Incepta Vaccine Ltd can produce any dose size from 0.

The yearly capacity is million vials and ampoules. To conduct the immunization program of EPI, yearly demand of vaccine is 21 million vials and other than EPI yearly demand is 10 million vials which is increasing day by day.

The production capacity of this facility is enough to meet the local demand and export. In near future Hepatitis B, Polio, Measles, Rubella, Tetanus antitoxin, Rabies immunoglobulin, Pentavalent and all other necessary vaccines will be manufactured.

Patent protection for pharmaceuticals in turkey

Incepta Vaccine Ltd is committed to provide all high tech life saving vaccines to the people at affordable price. More than 10 million people are suffering from hepatitis B virus infection.

Patent provisions of Turkey’s new IP Law | Managing Intellectual Property

Moreover, Bangladesh was fully dependent on imported vaccine to prevent this deadly infectious disease. Hepa-B is available in vial of 0.View recent copies of Biotech Daily with important stories on research and development (R&D), mergers and acquisitions (M&A), finance, government grants and regulation, share price movements, industry news and personnel appointments in Australian Stock Exchange listed biotechnology companies.

Patent protection for pharmaceuticals in turkey

THE REGULATION AND PATENT PROTECTION OF PHARMACEUTICALS IN TURKEY Ahmet Fatih ÖZKAN Turkiye Klinikleri J Med Ethics ;18(1) 17 On the demand side of the sector, there are. PATENT EXPIRY DATES 1/3. The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide.

Mar 04,  · In the United States, patent term extension is available under the Drug Price Competition and Patent Restoration Act, also known as the Hatch-Waxman Act ("The Act") Act allows the extension of the term of a patent claiming a product that requires regulatory approval prior to being sold, or a method of using or manufacturing the product.

Aug 10,  · In Turkey, patent protection rights terminate completely on the expiry of the patent protection term. Turkish law does not contain a mechanism to extend the protection period, similar to the supplementary protection certificate system which exists in the European Union.

Six other drugs by Lilly had sales of over $1 billion in These include Cialis, the famous erectile dysfunction drug with sales of $ billion and patent protection until

Generic pharmaceuticals and competition - OECD